Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
O'Neill WW, Serruys P, Knudtson M, van Es GA, Timmis GC, van der Zwaan C, Kleiman J, Gong J, Roecker EB, Dreiling R, Alexander J, Anders R. O'Neill WW, et al. N Engl J Med. 2000 May 4;342(18):1316-24. doi: 10.1056/NEJM200005043421803. N Engl J Med. 2000. PMID: 10793164 Free article. Clinical Trial.
Clinical and angiographic results with the beStent: the Registry for Optimal beStent Evaluation (ROSE) trial.
Suryapranata H, Boland JL, Pieper M, Legrand VL, Bonnier JJ, Juliard JM, Vrolix MC, Seabra-Gomes R, Hamburger JN, Roguin A, Oosterwijk C, Van Es GA, Beyar R, Serruys PW. Suryapranata H, et al. Among authors: serruys pw. Int J Cardiovasc Intervent. 2000 Mar;3(1):21-28. doi: 10.1080/14628840050516271. Int J Cardiovasc Intervent. 2000. PMID: 12470383
Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease.
Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F, Lee CH, Ruiter A, McFadden E, Sianos G, Smits PC, van der Giessen WJ, de Feijter P, van Domburg R, Serruys PW. Arampatzis CA, et al. Among authors: serruys pw. Am J Cardiol. 2003 Aug 1;92(3):327-9. doi: 10.1016/s0002-9149(03)00640-4. Am J Cardiol. 2003. PMID: 12888147 Clinical Trial.
Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II?
Gruberg L, Mercado N, Milo S, Boersma E, Disco C, van Es GA, Lemos PA, Ben Tzvi M, Wijns W, Unger F, Beyar R, Serruys PW; Arterial Revascularization Therapies Study Investigators. Gruberg L, et al. Among authors: serruys pw. Am J Cardiol. 2005 Feb 15;95(4):439-44. doi: 10.1016/j.amjcard.2004.10.007. Am J Cardiol. 2005. PMID: 15695125 Clinical Trial.
Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology.
Van Mieghem CA, Bruining N, Schaar JA, McFadden E, Mollet N, Cademartiri F, Mastik F, Ligthart JM, Granillo GA, Valgimigli M, Sianos G, van der Giessen WJ, Backx B, Morel MA, Van Es GA, Sawyer JD, Kaplow J, Zalewski A, van der Steen AF, de Feyter P, Serruys PW. Van Mieghem CA, et al. Among authors: serruys pw. Int J Cardiovasc Imaging. 2005 Aug;21(4):425-41. doi: 10.1007/s10554-004-7986-y. Int J Cardiovasc Imaging. 2005. PMID: 16047125
2,706 results